Introduction
Resolution of chronic intractable congestive heart failure in adults and pulmonary oedema superimposed on refractory heart failure in infants and children has been achieved by the use of peritoneal dialysis (Schneierson, 1949; Bertrand and Guerin, 1961; Nora et al., 1966; Mailloux et al., 1967; Cairns et al., 1968) . It therefore seemed reasonable to use this technique to treat pulmonary oedema after acute myocardial infarction when more conventional diuretic measures had failed to produce a satisfactory response. Such patients have a poor prognosis owing to the complications that arise from the associated severe anoxia, hypotension, and metabolic acidosis (Rosenbaum and Levine, 1941; Peel et al., 1962; MacKenzie, 1964; McNicol et al., 1965) . This paper describes our initial experience with this method of treating pulmonary oedema after acute myocardial infarction. 
Patients and Methods
Peritoneal dialysis was performed on four men with proved acute mlocardial infarction. The diagnosis was based on a typical clinical history with characteristic electrocardiographic changes (World Health Organization, 1959) and/or a significant rise in enzymes (aspartate aminotransferase and a-hydroxybutyrate dehydrogenase). The clinical details are summarized in Table I . Blood urea and serum electrolyte studies were carried out before and after dialysis. Serial arterial blood gas and acidbase studies were made on two patients (Table II) . Predialysis and post-dialysis portable anteroposterior chest radiographs, taken at a distance of 5 ft. (1-5 m.), were assessed for evidence of cardiac enlargement, pulmonary venous hypertension, pleural effusions, and pulmonary oedema with a modification of the method of Tattersfield et al. (1969) . Cardiac size was evaluated from the cardiothoracic ratio-namely, ratio less than 50 % = 0 mark; 51 % to 60% = 1 mark; 61 Y, or greater = 2 marks. Pulmonary venous hypertension was assessed by examination of the chest radiographs for (a) upper lobe pulmonary venous congestion (no congestion = 0 mark; mild congestion = 1 mark; marked congestion = 2 marks), and (b) evidence of septal lines (no septal lines = 0 mark; septal lines = 1 mark). A pleural effusion, if present, scored 1 mark. Pulmonary oedema was evaluated on the basis of its presence (1 mark) or absence (0 mark) in the upper, middle, and lower zones (assessed separately) of each lung field. This gave a possible maximum total of 6 marks and, though arbitrary, enabled us to record changes in the degree of oedema. Accurate measurement of the width of the superior mediastinum proved impossible; Tattersfield et al. (1969) also found this measurement unreliable. Peritoneal dialysis was performed under aseptic conditi,ons with the Trocath Peritoneal Dialysis Catheter (McGaw Laboratories). Three patients were dialysed in a cardiac monitoring unit and the fourth in a general medical ward. A vesical catheter was introduced before dialysis and left in situ until completion of the dialysis programme. Dialaflex No. 62 (Allen & Hanburys Ltd.) was used as the hypertonic dialysing fluid (dextrose BP. 6-36%, sodium lactate B.P.C. 0.5%, sodium chloride 0-56%, calcium chloride B.P. 0-039%, and magnesium chloride B.P.C. 0-015%). When the initial serum potassium was normal, 4 mEq of potassium chloride was added to each litre of fluid, which also contained 500 units of heparin. Each litre of dialysing fluid was run in over 10 minutes and allowed to remain in the peritoneal cavity for a further 10 minutes before being siphoned back by gravity. Each exchange was completed in 30 to 45 minutes. Details of the four dialyses are shown in Table III . . . 4 After dialysis (2/6/69) .
. . Table I ) and digitalization (ouabain), peritoneal dialysis was begun and continued for five and a half hours, during which 1,470 ml. of fluid was extracted (Table III) . His clinical condition improved rapidly and by 09.30 hours on 27 May the pulmonary oedema had disappeared (Table IV) (Table IV) .
Peritoneal dialysis was begun and continued for 10 hours. A significant negative fluid balance was not achieved but sinus rhythm returned two hours after beginning dialysis. Within 36 hours of completing dialysis the pulmonary oedema had disappeared. A satisfactory diuresis was then maintained with oral diuretics. His subsequent progress was very satisfactory until 16 days after dialysis when he developed unheralded cardiac arrest on the ward and attempts at resuscitation were unsuccessful. Necropsy confirmed both anterior and posterior myocardial infarction.
Discussion
The use of peritoneal dialysis in cardiac failure is a wellestablished procedure, but we have found no reference to its use after acute myocardial infarction. In the past five years intensive coronary care has considerably reduced the mortality from acute infarction, the figure for most established units now lying between 14',/,) and 20','. The chance of survival after primary ventricular fibrillation is high, and when infarction is complicated by heart block the prognosis may be improved by the use of artificial pacing (Paulk and Hurst, 1966; Scott et al., 1967; Chatterjee et al., 1969) . Persistent pulmonary oedema carries a poor prognosis, for in these patients the incidence of arrhythmias is high and it is often impossible to obtain a rise in the arterial oxygen tension without a satisfactory diuresis.
MEDICAL JOVNAL was that a satisfactory response to oral and parenteral diuretics occurred after dialysis, as has been reported by Mailloux et al. (1967) after using this technique in intractable chronic congestive heart failure.
So far our experience of peritoneal dialysis for pulmonary oedema after acute myocardial infarction is small, because nearly all patients respond to oral or intravenous diuretics. Nevertheless, since we believe that two of the four patients survived as a result of the procedure, we feel that it should be considered as an emergency measure when this problem is encountered.
We are grateful to Dr. A. E. Pratt, Consultant Radiologist, Kingston General Hospital, for his help in evaluating the chest radiographs.
Introduction
Vancomycin was first isolated in 1956 from Streptomyces orientalis and shown to be highly active in vitro against Gram-positive organisms. It is bactericidal in concentrations not much greater than those needed to achieve bacteriostasis, natural resistance to the drug is rare, and acquired resistance has not been reported. Vancomycin has, however, been of only limited clinical use, firstly because it must be given by intravenous infusion for systemic effect, secondly because it is ototoxic at excessively high serum levels, and, finally, because there are other non-toxic drugs with equally good bactericidal activity against staphylococci and streptococci.
Great care is needed in the use of vancomycin when renal function is impaired; Dutton and Elmes (1959) found severe loss of auditory acuity in four, possibly five, of nine patients after treatment with vancomycin, all of whom had some degree of renal failure. Geraci et al. (1958) reported perceptive deafness occurring in two patients, one of whom had renal insufficiency, with serum vancomycin levels of 80-100 ,ug./ml. The critical serum level below which eighth nerve toxicity does not occur is not known.
When Prompt effective treatment is essential to save the shunt and to avoid septicaemia. Ideally the antibiotic selected should be bactericidal, should have good antistaphylococcal activity, and should not be largely removed by haemodialysis, so that it can be given by intermittent infusion into the shunt. In these patients repeated intramuscular injections are best avoided because of the need for heparinization, and oral antibiotics often lead to nausea and vomiting. Vancomycin is particularly suitable for treatment of shunt site infections: it is bactericidal, highly active against staphylococci, is normally almost entirely excreted by the kidney, and is not removed by dialysis (Lindholm and Murray, 1966) . Intermittent administration will therefore produce therapeutic levels in anuric patients which persist for some time.
Patients and Methods
Sensitivity of Staphylococci to Vancomycin.-Minimum inhibitory concentrations of vancomycin were determined for a range of hospital staphylococci, D.S.T. agar (Oxoid) with an inoculum of 0-02 ml. of a broth culture containing about 10' organisms per ml. being used. The results were read after 24 hours' incubation. The staphylococci tested included both coagulase-positive and coagulase-negative strains; they were selected to include a range of sensitivities t-o other antibiotics and many showed multiple resistance.
Patients.-Six patients (four men, two women) aged 19-32 years were treated with vancomycin for shunt site infections. All were having regular haemodialysis for end-stage renal failure and two were anephric. Swabs for bacteriological examination were taken from the shunt site of each patient before vancomycin was given and in three cases the minimum inhibitory concentration of vancomycin was determined for the organism isolated. Further cultures were taken from some patients during treatment. The initial dose of vancomycin was 1 g. in four patients and 0 5 g. in two; these doses were repeated when the serum level of the drug fell below a therapeutic level. The antibiotic was given by slow infusion into the venous line during the final 30 to 60 minutes of dialysis. Three of the six patients were also treated with intermittent
